Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians, and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Business segments
Q1 2026 · $2.90BThe company’s own SEC segment disclosure.
- Diagnostic Information Services Business$2.83B98%
- All Other$63.0M2%
Quest Diagnostics (DGX) reported revenue of $2.90B in Q1 2026 (quarter ended March 31, 2026), up 9.2% from the same quarter a year earlier. That came with a gross margin of 33% and net income of $252M (8.7% of revenue). For the full year FY2025, revenue was $11.0B (+12% year on year) and net income $992M. Its largest segment in 2026-Q1 was Diagnostic Information Services Business at $2.83B, 98% of the disclosed total, just ahead of All Other at 2.2%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Diagnostics & Research
Ranks #24 of 29 by Smart Score